🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
This phase I trial studies the side effects and best way to give metformin ...
Status
Withdrawn
Location
Fox Chase Cancer Center
Start Date
TBD
Trial ID
NCT02050009
Treatments Being Tested
This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Start Date
2021-05-21
Trial ID
NCT04704934
Treatments Being Tested
The investigators preliminary data suggests that FOLFOX-A may have equal or...
Status
Completed
Location
Roxanne Wood
Start Date
2014-02-01
Trial ID
NCT02022033
Treatments Being Tested
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
This phase 3 trial compares the addition of nivolumab to chemotherapy (carb...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-11-17
Trial ID
NCT04444921
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Status
Active Not Recruiting
Location
Regional Medical Center
Start Date
2003-11
Trial ID
NCT00070564
Treatments Being Tested
This study was originally designed as a Phase III randomized, double blind,...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-12-13
Trial ID
NCT00272987
Treatments Being Tested
This is a phase Ib single arm, open-label, multiple dose, dose escalating, ...
Status
Completed
Location
Oncology Institute of Southern Switzerland (IOSI)
Start Date
2014-04
Trial ID
NCT02069158
Treatments Being Tested